Nonprofits›New York Hospital Cornell Medical Center Fund Inc
Health Care
New York Hospital Cornell Medical Center Fund Inc
NEW YORK, NY
Total revenue
$14.0M
Total expenses
$8.7M
Net assets
$249.4M
Grants received
$7.2M
68 grants
EIN
136094042
Tax year
2023
Mission
Solicit, receive, and administer gifts and contributions for the society of the new york presbyterian hospital and weill medical college of cornell university.
Programs
1 program
Support of the society of the new york presbyterian hospital
Expenses: $2.6MGrants: $2.6M
Financials
FY 2023
Revenue
Contributions & grants$212K
Program service revenue—
Investment income$13.8M
Other revenue—
Total revenue$14.0M
Expenses
Grants paid$8.0M
Salaries & benefits—
Fundraising—
Other expenses$623K
Total expenses$8.7M
Total assets$249.4M
Net assets$249.4M
People
9 listed
NameRoleCompensation
JOHN S WEINBERG
PRESIDENT
Board
—
1 hrs/wk
KRAIG KAYSER
VICE PRESIDENT (AS OF 5/22/24)
Board
—
1 hrs/wk
ANDREW H TISCH
VICE PRESIDENT
Board
—
1 hrs/wk
STEVEN O NEWHOUSE
VICE PRESIDENT
Board
—
1 hrs/wk
MELISSA E WELCH
ASSISTANT SECRETARY
Board
—
1 hrs/wk
VANESSA M MURPHY
ASSISTANT SECRETARY (AS OF 5/22/24)
Board
—
1 hrs/wk
ERIN K ANTHONY
ASSISTANT TREASURER
Board
—
1 hrs/wk
JOSEPH SCHWARTZ
TREASURER (UNTIL 1/5/24)
Board
—
1 hrs/wk
JOHN CAMPANO
SECRETARY
Board
—
1 hrs/wk
Grants received
Showing 68 of 68
FromAmountPurposeYear
$403K
SEX-BIASED TLR7 SIGNALING IN DEMYELINATION AND ITS INHIBITION BY SMALL MOLECULES
2024
$201K
TAU-INDUCED POSTSYNAPTIC DYSFUNCTION IN TAUOPATHY MODELS
2024
$201K
IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS
2024
$288K
BEE: BIOCHEMICAL AND FUNCTIONAL ANALYSIS OF CSF AND LYMPH FOLLOWING CHANGES IN BRAIN FLUID DYNAMICS
2023
$250K
DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMER'S DISEASE
2023
$201K
IDENTIFICATION AND DEVELOPMENT OF CD33 INHIBITORS AND PRE-RNA SPLICING MODULATORS
2023
$201K
TAU-INDUCED POSTSYNAPTIC DYSFUNCTION IN TAUOPATHY MODELS
2023
$53K
CHARACTERIZING THE ROLE AND TARGETING OF THE HISTONE METHYLTRANSFERASE SETD2 IN MULTIPLE MYELOMA.
2023
$288K
BEE: BIOCHEMICAL AND FUNCTIONAL ANALYSIS OF CSF AND LYMPH FOLLOWING CHANGES IN BRAIN FLUID DYNAMICS
2022
$250K
DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMERS DISEASE
2022
$173K
GUT MICROBIOTA, ENDOTHELIAL DYSFUNCTION AND TAU-MEDIATED COGNITIVE IMPAIRMENT
2022
$173K
ROLE OF MICROGLIA IN DEGRADATION AND TRIMMING OF ALZHEIMERS AMYLOID BETA
2022
$127K
COSTS OF PARTICIPATING IN MIPS FOR PHYSICIAN PRACTICES RESEARCH PROJECT
2022
$103K
TO SUPPORT THE CHILDREN'S BRAIN TUMOR PROJECT GOAL TO BRING HOPE TO THE HUNDREDS OF PATIENTS AND FAMILIES EACH YEAR WHO CONFRONT THESE HEARTBREAKING DIAGNOSES. THE GROUNDBREAKING RESEARCH INITIATIVE FOCUSES ON RESEARCHING AND TESTING ALTERNATIVE THERAPEUTIC DELIVERY SYSTEMS FOR OTHER INOPERABLE BRAIN CANCERS, SUCH AS DIPG.
2022
$250K
DEVELOPMENT OF HUMAN CGAS INHIBITORS TO TREAT ALZHEIMER'S DISEASE
2021
$173K
ROLE OF MICROGLIA IN DEGRADATION AND TRIMMING OF ALZHEIMER'S AMYLOID BETA
2021
$173K
BRAIN ENTRY AND EXIT CONSORTIUM: LYMPHATICS AND CNS FLUID HOMEOSTASIS
2021
$103K
TO SUPPORT THE CHILDREN'S BRAIN TUMOR PROJECT GOAL TO BRING HOPE TO THE HUNDREDS OF PATIENTS AND FAMILIES EACH YEAR WHO CONFRONT THESE HEARTBREAKING DIAGNOSES. THE GROUNDBREAKING RESEARCH INITIATIVE FOCUSES ON RESEARCHING AND TESTING ALTERNATIVE THERAPEUTIC DELIVERY SYSTEMS FOR OTHER INOPERABLE BRAIN CANCERS, SUCH AS DIPG.
2021
$173K
GUT MICROBIOTA, ENDOTHELIAL DYSFUNCTION AND TAU-MEDIATED COGNITIVE IMPAIRMENT
2020
$61K
TO SUPPORT THE CHILDREN'S BRAIN TUMOR PROJECT GOAL TO BRING HOPE TO THE HUNDREDS OF PATIENTS AND FAMILIES EACH YEAR WHO CONFRONT THESE HEARTBREAKING DIAGNOSES. THE GROUNDBREAKING RESEARCH INITIATIVE FOCUSES ON RESEARCHING AND TESTING ALTERNATIVE THERAPEUTIC DELIVERY SYSTEMS FOR OTHER INOPERABLE BRAIN CANCERS, SUCH AS DIPG.
2020
$10K
FOR UNRESTRICTED SUPPORT IN HONOR OF DR. MARK PASMANTIER & DR. ROGER HARTL AT THE REQUEST OF CAROLINE & SERGE LUSSI
2020
$173K
AD RISK IS HIGHER IN WOMEN: IDENTIFICATION OF FEMALE SPECIFIC BRAIN BIOENERGETIC TARGETS
2019
$173K
DIETARY SALT TAU PHOSPHRYLATION AND COGNITIVE IMPAIRMENT
2019
$65K
TO SUPPORT THE CHILDREN'S BRAIN TUMOR PROJECT GOAL TO BRING HOPE TO THE HUNDREDS OF PATIENTS AND FAMILIES EACH YEAR WHO CONFRONT THESE HEARTBREAKING DIAGNOSES. THE GROUNDBREAKING RESEARCH INITIATIVE FOCUSES ON RESEARCHING AND TESTING ALTERNATIVE THERAPEUTIC DELIVERY SYSTEMS FOR OTHER INOPERABLE BRAIN CANCERS, SUCH AS DIPG.
2019
—
TO SUPPORT THE CHILDREN'S BRAIN TUMOR PROJECT GOAL TO BRING HOPE TO THE HUNDREDS OF PATIENTS AND FAMILIES EACH YEAR WHO CONFRONT THESE HEARTBREAKING DIAGNOSES. THE GROUNDBREAKING RESEARCH INITIATIVE FOCUSES ON RESEARCHING AND TESTING ALTERNATIVE THERAPEUTIC DELIVERY SYSTEMS FOR OTHER INOPERABLE BRAIN CANCERS, SUCH AS DIPG.
2018
$40K
RESEARCH GRANT - CHANGES IN COUGH STRENGTH IN PATIENTS WITH UNILATERAL VOCAL FOLD PARALYSIS AFTER INJECTION LARYNGOPLASTY
2017
$25K
TO SUPPORT THE CHILDREN'S BRAIN TUMOR PROJECT GOAL TO BRING HOPE TO THE HUNDREDS OF PATIENTS AND FAMILIES EACH YEAR WHO CONFRONT THESE HEARTBREAKING DIAGNOSES. THE GROUNDBREAKING RESEARCH INITIATIVE FOCUSES ON RESEARCHING AND TESTING ALTERNATIVE THERAPEUTIC DELIVERY SYSTEMS FOR OTHER INOPERABLE BRAIN CANCERS, SUCH AS DIPG.
2017
Funded by
$7.2M from 26 funders · 68 grants · 2017–2024
Alzheimer's Disease Research Foundation
$4.4M · 21 grants · 2019–2024
National Alliance For Research On Schizophrenia And Depression
$665K · 4 grants · 2020–2024
The Fashion Footwear Charitable
$555K · 5 grants · 2018–2023
Ty Louis Campbell Foundation Inc
$356K · 6 grants · 2017–2022
Stxbp1 Foundation
$251K · 3 grants · 2022–2024
Ira Sohn Conference Foundation
$245K · 1 grant · 2020
American Medical Association
$127K · 1 grant · 2022
Governing Council Of The University Of Toronto
$82K · 2 grants · 2020–2021
Details
EIN136094042
NTEE codeE120
Subsection03
Ruling date1958-06
Formed1956
Employees0
Volunteers4